PMID: 15243212Jul 10, 2004Paper

Paraoxonase 1 activity, concentration and genotype in cardiovascular disease

Current Opinion in Lipidology
Mike MacknessBharti Mackness

Abstract

To provide up-to-date information on the most recent advances in the epidemiology, biochemistry and molecular biology of the antiatherosclerotic enzyme paraoxonase 1. Case-control and prospective studies published during the period covered by this review have indicated that paraoxonase 1 'status' (i.e. activity and/or concentration) was a more important coronary heart disease risk factor than the paraoxonase 1 genetic polymorphisms. New findings on the role of paraoxonase 1 in homocysteine metabolism are reviewed, as are advances in the nutritional and pharmacological regulation of paraoxonase 1. The recent controversy over whether paraoxonase 1 or platelet-activating factor acetylhydrolase is responsible for the antioxidant activity of high-density lipoprotein is also addressed. In the light of recent findings, we believe that genetic epidemiological studies of the paraoxonase 1 polymorphisms in relation to coronary heart disease should no longer be undertaken unless they are very large and prospective in nature. More research should be undertaken to discover the biochemical mechanisms underlying the mode of action of paraoxonase 1 and the factors which modulate its activity and/or concentration. Bharti Mackness is funded by t...Continue Reading

References

Jul 29, 1991·FEBS Letters·M I MacknessP N Durrington
Oct 1, 1987·Pharmacology, Biochemistry, and Behavior·J M WehnerT N Smolen
Mar 24, 2000·Clinical Science·B MacknessM I Mackness
Aug 17, 2000·Current Opinion in Lipidology·M I MacknessB Mackness
Nov 14, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·G P JarvikC E Furlong
Feb 15, 2001·The Biochemical Journal·L RodrigoM I Mackness
Apr 17, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·P N DurringtonM I Mackness
May 4, 2001·American Journal of Human Genetics·V H BrophyC E Furlong
Sep 15, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·B MacknessM I Mackness
Aug 2, 2002·Current Opinion in Lipidology·Bharti MacknessMichael I Mackness
Aug 13, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·P N DurringtonM I Mackness
Aug 13, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Gail P JarvikClement E Furlong
Dec 31, 2002·Biochemical and Biophysical Research Communications·Polkit SangvanichMichael Mackness
Feb 18, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Xiaoling WangDongfeng Gu
Feb 26, 2003·Metabolism: Clinical and Experimental·G FerrettiG Curatola
Mar 20, 2003·Molecular Pharmacology·Cédric GouédardYannick Morel
Mar 26, 2003·Free Radical Biology & Medicine·Azhar bin AliSai-Kiang Lim
May 16, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Monique Vincent-VirySophie Visvikis
May 21, 2003·Circulation·Bharti MacknessMichael Mackness
Jun 5, 2003·Journal of the National Cancer Institute·Marja MarchesaniJukka T Salonen
Jun 12, 2003·The Journal of Biological Chemistry·Karine RobertNathalie Janel
Jun 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Gail P JarvikClement E Furlong
Sep 23, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Sara DeakinRichard W James
Oct 18, 2003·Metabolism: Clinical and Experimental·Manjunath N RaoM Raj Lakshman
Nov 26, 2003·Biochimica Et Biophysica Acta·Kirsty S RobertsonUNKNOWN Northwick Park Heart Study II
Jan 16, 2004·Experimental Gerontology·Ildiko SeresAbdelouahed Khalil

❮ Previous
Next ❯

Citations

Apr 4, 2007·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Aydin EceOzcan Erel
Jul 13, 2011·Cell Biochemistry and Biophysics·Xing-Liang JiangJuan Du
Jun 25, 2013·Biochemical and Biophysical Research Communications·Chi-Chih ChengShih-Lan Hsu
Nov 20, 2009·BMC Clinical Pharmacology·Leonid GaidukovEtgar Levy-Nissenbaum
Jul 17, 2008·Vascular Health and Risk Management·Navin K KapurRoger S Blumenthal
Dec 30, 2011·American Journal of Veterinary Research·Asta TvarijonaviciuteJosé Cerón
Aug 1, 2013·Indian Journal of Human Genetics·M R Mogarekar, Seema S Chawhan
Jul 9, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Harald ManggeRuth Prassl
Sep 28, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Alejandro Gugliucci, Teresita Menini
Oct 6, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Binita GoswamiV Mallika
Jun 23, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Robin P F DullaartLars B Nielsen
Jan 15, 2009·Biochemical and Biophysical Research Communications·Maokai GongRaj M Lakshman
Mar 26, 2009·Clinical Biochemistry·Aleksandra StefanovićNada Bujisić
Nov 11, 2008·Life Sciences·Rafael de Lima PortellaFélix Alexandre Antunes Soares
Aug 17, 2006·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Tetsuo Shoji, Yoshiki Nishizawa
Oct 1, 2011·European Journal of Clinical Investigation·Paul J W H KappelleUwe J F Tietge
Dec 17, 2009·British Journal of Clinical Pharmacology·S A PereiraE C Monteiro
Sep 30, 2004·Free Radical Biology & Medicine·Mike Mackness, Bharti Mackness
Sep 1, 2004·Biochemical and Biophysical Research Communications·Bianca FuhrmanMichael Aviram
Oct 31, 2006·Biochemical and Biophysical Research Communications·Orit Rozenberg, Michael Aviram
Aug 1, 2006·Clinical Biochemistry·Mohsen KerkeniKhira Maaroufi
May 11, 2015·Biochimica Et Biophysica Acta·Suzy Eryanni-LevinAndrea Szuchman-Sapir
May 18, 2012·Journal of Enzyme Inhibition and Medicinal Chemistry·Esra Bayram DilekŞükrü Beydemir
Nov 28, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Alejandro Gugliucci
Jul 30, 2014·Journal of Toxicology and Environmental Health. Part a·G GinsbergP Lewandowski
Jul 7, 2009·European Journal of Pharmacology·Deniz Ekinci, Sükrü Beydemir
Jul 28, 2016·Human & Experimental Toxicology·S KaradasH Demir
Jul 4, 2006·Journal of Lipid Research·Elena Thomàs-MoyàIsabel Lladó
Jul 13, 2006·Current Opinion in Lipidology·Mohamad NavabAlan M Fogelman
Feb 18, 2005·Current Opinion in Clinical Nutrition and Metabolic Care·Arnold von EckardsteinLucia Rohrer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.